SG Americas Securities’s Insmed INSM Stock Holding History

SG Americas Securities’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-24,000	Closed	-$1K	–	3037
2021 Q1	$1K	Buy	+24,000	New	+$917K	﹤0.01%	3226

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SG Americas Securities's INSM Position: Q1 2026 in Review

SG Americas Securities increased its Insmed (INSM) stake by 105% in Q1 2026, buying an estimated $10.8M and bringing the position to 137,149 shares worth $22.4M. The position accounts for 0.02% of the portfolio, ranked #497.

SG Americas Securities first reported a position in INSM in Q4 2014 and has held it in 36 quarters since. 670 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

SG Americas Securities held 137,149 shares of Insmed worth $22.4M as of Q1 2026.
SG Americas Securities bought 70,387 Insmed shares in Q1 2026, an estimated $10.8M.
Insmed made up 0.02% of SG Americas Securities's portfolio in Q1 2026, its #497 holding.
SG Americas Securities first reported a position in Insmed in Q4 2014 and has held it in 36 quarters since.
670 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.